Linc-ROR promotes esophageal squamous cell carcinoma progression through the derepression of SOX9
2017 · Journal of Experimental & Clinical Cancer Research · 63 citations
https://doi.org/10.1186/s13046-017-0658-2
L
Lianghai Wang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
1.4K
Citations
23
h-index
38
i10-index
Lianghai Wang is an academic researcher from Shihezi University. The author has contributed to research in topics: RNA modifications and cancer & Cancer-related molecular mechanisms research & Esophageal Cancer Research and Treatment. The author has an h-index of 23, co-authored 64 publications.
ORCID: 0000-0003-3128-7780Papers by this author
worksThree novel circRNAs upregulated in tissue and plasma from hepatocellular carcinoma patients and their regulatory network
2021 · Cancer Cell International · 24 citations
https://doi.org/10.1186/s12935-021-01762-w
p53 expression but not p16INK4A correlates with human papillomavirus-associated esophageal squamous cell carcinoma in Kazakh population
2016 · Infectious Agents and Cancer · 23 citations
https://doi.org/10.1186/s13027-016-0065-x
Epigenetically associated IGF2BP3 upregulation promotes cell proliferation by regulating E2F1 expression in hepatocellular carcinoma
2024 · Scientific Reports · 10 citations
https://doi.org/10.1038/s41598-024-67021-w
Low expression of PINK1 and PARK2 predicts poor prognosis in patients with esophageal squamous cell carcinoma
2023 · World Journal of Surgical Oncology · 5 citations
https://doi.org/10.1186/s12957-023-03206-3
EPRS1 correlates with malignant progression in hepatocellular carcinoma
2023 · Infectious Agents and Cancer · 3 citations
https://doi.org/10.1186/s13027-023-00503-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat